Métodos de valoración de la adherencia al tratamiento psiquiátrico en la práctica clínica

  1. Carlos De las Cuevas 1
  2. Emilio J. Sanz 1
  1. 1 Universidad de La Laguna, España
Revue:
Revista iberoamericana de psicología y salud

ISSN: 2171-2069

Année de publication: 2016

Volumen: 7

Número: 1

Pages: 25-30

Type: Article

DOI: 10.1016/J.RIPS.2015.10.001 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Revista iberoamericana de psicología y salud

Résumé

Adherence to adequately prescribed medications is essential for an effective psychopharmacotherapy. Non-adherence to psychoactive medications is a significant barrier to the successful treatment of psychiatric disorders in the clinical practice and has been linked to poor treatment outcomes such as increased risk of relapse and recurrence, as well as increased healthcare costs. Adherence to prescribed treatments in psychiatric practice is a multifactorial issue that includes patient-centered factors, therapy-related factors, healthcare system factors, social and economic factors, and disease factors. However, despite the relevance of the contribution of that group of variables in predicting adherence, a considerable level of unexplained variance still remain. Moreover, there is no ‘gold standard’ measure of medication adherence since all available methods have their limitations. This paper focuses on the difficulties involved in evaluating psychiatric patients’ adherence in real clinical world and describes the most relevant methods to assess adherence.

Références bibliographiques

  • Atkins, L. y Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. European Journal of Cancer, 42, 2271-2276.
  • Brown, C., Battista, D. R., Bruehlman, R., Sereika, S. S., Thase, M. E. y Dunbar-Jacob, J. (2005). Beliefs about antidepressant medications in primary care patients: Relationship to self-reported adherence. Medical Care, 43,1203-1207.
  • Cassidy, C. M., Rabinovitch, M., Schmitz, N., Joober, R. y Malla, A. (2010). A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. Journal of Clinical Psychopharmacolology, 30, 64-67.
  • Chakraborty, K., Avasthi, A., Kumar, S. y Grover, S. (2009). Attitudes and beliefs of patients of first episode depression towards anti-depressants and their adherence to treatment. Social Psychiatry and Psychiatric Epidemiology, 44, 482-488.
  • Clayton, C. D., Veach, J., Macfadden, W., Haskins, J., Docherty, J. P. y Lindenmayer, J. P. (2010). Assessment of clinician awareness of nonadherence using a new structured rating scale. Journal of Psychiatric Practice, 16, 164-169.
  • Cramer, J. A. y Rosenheck, R. (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
  • Cribb, A., & Barber, N. (2005). Unpicking the philosophical and ethical issues in medicines prescribing and taking, in ‘‘Concordance, Adherence and Compliance in Medicine Taking’’. Report from the National Coordinating Centre for NHS Service Delivery and Organisation R&D. (NCCSO).
  • De las Cuevas, C. (2011). Towards a clarification of terminology in medicine taking behavior: Compliance, adherence and concordance are related although different terms with different uses. Current Clininical Pharmacolology, 6, 74-77.
  • De las Cuevas, C. y De Rivera, L. (1994). Cumplimiento de a medicación neuroléptica y curso de la esquizofrenia. Psiquis, 15, 11-20.
  • De las Cuevas, C. y Peñate, W. (2015). Psychometric Properties of the eight-Item Morisky Medication Adherence Scale (MMAS-8) in Psychiatric Outpatient Setting. International Journal of Clinical and Health Psychology, 15, 121-129.
  • De las Cuevas, C.,Peñate, W. y Sanz, E. J. (2013). Psychiatric outpatients’ self-reported adherence versus psychiatrists’ impressions on adherence in affective disorders. Human Psychopharmacology: Clinical and Experimental, 28, 142-150.
  • De las Cuevas, C., Rivero-Santana, A., Perestelo-Perez, L., Gonzalez-Lorenzo, M., Perez-Ramos, J. y Sanz, E. J. (2011). Adaptation and validation study of the Beliefs about Medicines Questionnaire in psychiatric outpatients in a community mental health setting. Human Psychopharmacology: Clinical and Experimental, 26, 140-146.
  • De las Cuevas, C. y Sanz, E. (2004). Do therapeutic indications of antidepressants change from one year to another? Pharmacoepidemiology and Drug Safety. 13, 309-314.
  • De las Cuevas, C., Sanz, E. y De la Fuente, J. (2002). Variations in Antidepressant Prescribing Practice. ¿Clinical Need or MarketInfluences? Pharmacoepidemiology and Drug Safety, 11, 515-522.
  • De las Cuevas, C., Zereck, E., Domínguez, A., Touriño, R., Winter, G., Domínguez, P., Ebro, S. y De la Fuente, J. (1996). Cumplimiento de las citas concertadas. Psiquis, 17, 445-464.
  • Dilla, T., Ciudad, A. y Alvarez, M. (2013). Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Journal of Patient Preference and Adherence, 7, 275-284.
  • Hansen, H. V. y Kessing, L. V. (2007). Adherence to antidepressant treatment. Expert Review of Neurotherapeutics, 7, 57-62.
  • Haro, J. M., Palacín, C., Vilagut, G., Martínez, M., Bernal, M. y Luque, I. (2006). Prevalencia y factores asociados de los trastornos mentales en España: Resultados del estudio ESEMED-España. Medicina Clínica (Barcelona), 126, 442-451.
  • Harris, C. M., Heywood, P. L. y Clayden, A. D. (1990). The Analysis of Prescribingin General Practice: A Guide to Audit and Research HSMO. London: Stationery Office Books.
  • Hogan, T. P., Awad, A. G. y Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13, 177-183.
  • Horne, R., Weinman, J. y Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14, 1-24.
  • Jónsdóttir, H., Friis, S., Horne, R., Pettersen, K. I., Reikvam, A. y Andreassen, O. A. (2009). Beliefs about medications: Measurement and relation ship to adherence in patients with severe mental disorders. Acta Psychiatrica Scandinavica, 119, 78-84.
  • Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., Ustün, T. B. y Wang, P. S. (2009). The global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys. Epidemiologia e Psichiatria Sociale, 18, 23-33.
  • Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G. y Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892-909.
  • Lingam, R. y Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105, 164-172.
  • Morisky, D. E., Ang, A., Krousel-Wood, M. y Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348-354.
  • Nielsen, R. E., Lindström, E., Nielsen, J. y Levander, S. (2012). DAI-10 is as good as DAI-30 inschizophrenia. European Neuropsychopharmacology, 22, 747-750.
  • Organización Mundial de la Salud, OMS. (2004). Invertir en salud mental. Ginebra: OMS.
  • Ormel, J., VonKorff, M., Ustun, T. B., Pini, S., Korten, A. y Oldehinkel, T. (1994). Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. The Journal of the American Journal Association, 272, 1741-1748.
  • Palop-Larrea, V. y Martínez-Mir, I. (2004). Adherencia al tratamiento en el paciente anciano. Información Terapéutica del Sistema Nacional de Salud, 28, 113-120.
  • Perlick, D. A., Rosenheck, R. A., Kaczynski, R. y Kozma, L. (2004). Medication non-adherence in bipolar disorder: A patient-centered review of research findings. Clinical Approaches in Bipolar Disorders, 3, 56-64.
  • Russell, J. y Kazantzis, N. (2008). Medication beliefs and adherence to antidepressants in primary care. The New Zealand Medical Journal, 121, 14-20.
  • Sabaté, E. (2003). Adherence to long-term therapies evidence for action. Geneva: WHO.
  • Sajatovic, M., Velligan, D. I., Weiden, P. J., Valenstein, M. A. y Ogedegbe, G. (2010). Measurement of psychiatric treatment adherence. Psychosomatic Research, 69, 591-599.
  • Thompson, K., Kulkarni, J. y Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42, 241-247.
  • Velligan, D. I., Lam, Y. W., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky ,L. y Miller, A. L. (2006). Defining and assessing adherence to oral antipsychotics: A review of the literature. Schizophrenia Bulletin, 32, 724-742.
  • Velligan, D. I., Wang, M., Diamond, P., Glahn, D. C., Castillo, D., Bendle, S., Lam, Y. W., Ereshefsky, L. y Miller, A. L. (2007). Relation ships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services, 58, 1187-1192.
  • World Health Organization, WHO. (2014). Mental disorders. Fact sheet Nº396. Geneve: WHO.
La source de données: Dialnet